Amidst a prolonged federal government shutdown and one year away from the 2026 election, the October 2025 Texas Politics Project poll finds Texas voters reporting worsening personal economic ...

Children’s math negativity adversely impacts their dedication and successful learning. Here, we’ll suggest interventions to ...

TOKYO & BASKING RIDGE, N.J., October 06, 2025--(BUSINESS WIRE)--Positive topline results from the TROPION-Breast02 phase 3 trial showed DATROWAY ® (datopotamab deruxtecan) demonstrated a statistically ...

Enhertu plus pertuzumab received FDA Priority Review for first-line treatment of HER2-positive metastatic breast cancer, based on DESTINY-Breast09 trial results. DESTINY-Breast09 trial showed a 44% ...

NEW YORK – The US Food and Drug Administration has accepted AstraZeneca and Daiichi Sankyo's supplemental biologics license application (sBLA) seeking approval for Enhertu (trastuzumab deruxtecan) ...

The Tennessee Titans' offensive line has allowed the most sacks and pressures in the NFL through two weeks. Despite poor performance, coaches Brian Callahan and Nick Holz feel better about their ...

Americans’ views of President Donald Trump’s job performance remain negative amid a flurry of activity from his administration on tariffs, immigration and public health, according to the latest NBC ...

NEW YORK – Grail on Wednesday reported positive top-line performance and safety results from its Pathfinder 2 study, finding that adding its multi-cancer early detection (MCED) test to ...

Four months into his second tour of duty in the White House, President Donald Trump's approval ratings remain slightly underwater. The president stands at 46% approval and 54% disapproval in a new ...

Between April 2019 and October 2022, 136 and 62 patients were randomly assigned to palbociclib plus ET or ET alone, respectively. Median investigator-assessed PFS was 4.9 months (95% CI, 3.6 to 6.1) ...